701. Comparison of MIC Results for Gepotidacin by Agar Dilution and Broth Microdilution Methods

BACKGROUND: Gepotidacin (GSK2140944) is a novel triazaacenaphthylene bacterial type II topoisomerase inhibitor in clinical development for the treatment of gonorrhea and uncomplicated UTI (acute cystitis). Gepotidacin selectively inhibits bacterial DNA gyrase and topoisomerase IV by a unique mechani...

詳細記述

保存先:
書誌詳細
出版年:Open Forum Infect Dis
主要な著者: Arends, S J Ryan, Canino, Michele A, Roth, Brieanna M, Rhomberg, Paul R, Flamm, Robert K, Scangarella-Oman, Nicole
フォーマット: Artigo
言語:Inglês
出版事項: Oxford University Press 2019
主題:
Abstracts
オンライン･アクセス:https://ncbi.nlm.nih.gov/pmc/articles/PMC6811067/
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/ofid/ofz360.769
タグ: タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!

類似資料